NEW YORK (TheStreet) -- CHANGE IN RATINGS
FMC was downgraded at Piper Jaffray to neutral from overweight. Valuation call, based on a 12-month price target of $87.
was upgraded at Drexel Hamilton to buy. Twelve-month price target is $46. Company offers growth at a reasonable price, Drexel Hamilton said.
Triumph(TGI) - Get Report was downgraded at RBC Capital to sector perform from outperform. Twelve-month price target is now $71. Company could face increased charges and business disruptions, RBC Capital said.
Team Health Holdings (TMH) was initiated at UBS with a buy rating. Major beneficiary of health care reform with steady core growth, UBS said. Twelve-month price target is $54.
Wesco Aircraft(WAIR) - Get Report was upgraded at RBC Capital to outperform from sector perform. Twelve-month price target is $27. Company can grow organically and through acquisitions, RBC Capital said.
Stock Comments / EPS Changes
Access Midstream Partners (ACMP) price target, EPS estimates were increased at Jefferies. Shadow backlog and acquisitions could drive incremental cash flow. Twelve-month price target is now $64. Buy rating.
Alexion Pharmaceuticals(ALXN) - Get Report price target, EPS estimates were increased at UBS. Well-positioned with faster ramp of sales in France and opportunity to lever the operating model, UBS said. Twelve-month price target is now $202. Buy rating.
DDR (DDR) price target was raised at UBS. Sale of Brazil investment removes overhang associated with region's macro issues and supply concerns in the retail real estate market, UBS said. Twelve-month price target is $21. Buy rating.
numbers were reduced at Nomura. Twelve-month price target is now $39. Estimates also reduced, given challenges at the core retail store, Nomura said. Neutral rating.
This article was written by a staff member of TheStreet.